Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if QURE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
59 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
255 filers reported a long position in QURE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Avoro Capital Advisors LLC | $309.9M | 6.7M | +12.9% |
| JPMORGAN CHASE & CO | $230.8M | 4.9M | +71.6% |
| RTW INVESTMENTS, LP | $181.5M | 3.9M | +52.4% |
| STATE STREET CORP | $133.8M | 2.9M | +28.5% |
| Aberdeen Group plc | $131.2M | 2.8M | -46.3% |
| BlackRock, Inc. | $86.5M | 1.9M | +8.3% |
| ORBIMED ADVISORS LLC | $83.3M | 1.8M | -15.4% |
| JANE STREET GROUP, LLC | $74.2M | 1.6M | +153.2% |
| JENNISON ASSOCIATES LLC | $71.9M | 1.6M | +26.6% |
| Boxer Capital Management, LLC | $69.2M | 1.5M | +127.1% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.